CYP2C8 and malaria: Zanzibar, where AS–AQ has been first-line treatment for uncomplicated malaria since 2003, has a similar CYP2C8*2 (13.9 %) frequency but higher CYP2C8*3 (2.1 %) allele frequency than most other places in sub-Saharan Africa [16, 18].